Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christal D Sohl

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|December 14, 2011
Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicityChristal D Sohl, Kamlendra Singh, Rajesh Kasiviswanathan, et al.
The Journal of Biological Chemistry|January 12, 2008
Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand bindingChristal D Sohl, Emre M Isin, Robert L Eoff, et al.
Biochemistry|December 24, 2019
Water Networks and Correlated Motions in Mutant Isocitrate Dehydrogenase 1 (IDH1) Are Critical for Allosteric Inhibitor Binding and ActivityJennifer M Chambers, Wade Miller, Giovanni Quichocho, et al.
Molecular Pharmacology|April 20, 2012
Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptaseChristal D Sohl, Rajesh Kasiviswanathan, Jiae Kim, et al.
CBE Life Sciences Education|August 22, 2024
The Making of Future Scientists: Faculty Mentor Cultural Awareness and Inclusive Science LabsIvan A Hernandez, Oliva Mota Segura, Rosalva Romero Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γChristal D Sohl, Michal R Szymanski, Andrea C Mislak, et al.
Biochemistry|February 28, 2023
Capturing the Dynamic Conformational Changes of Human Isocitrate Dehydrogenase 1 (IDH1) upon Ligand and Metal Binding Using Hydrogen-Deuterium Exchange Mass SpectrometryKaitlyn A Sabo, Elene Albekioni, Danielle Caliger, et al.
The Journal of Biological Chemistry|March 24, 2017
Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiencyDiego Avellaneda Matteo, Adam J Grunseth, Eric R Gonzalez, et al.
Biochemistry|April 3, 2023
Insights into Nitrosoalkane Binding to Myoglobin Provided by Crystallography of Wild-Type and Distal Pocket Mutant DerivativesViridiana E Herrera, Tatyana P Charles, Tiala G Scott, et al.
The Biochemical Journal|September 26, 2018
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutantsDiego Avellaneda Matteo, Grace A Wells, Lucas A Luna, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|December 14, 2011
Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicityChristal D Sohl, Kamlendra Singh, Rajesh Kasiviswanathan, et al.
The Journal of Biological Chemistry|January 12, 2008
Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand bindingChristal D Sohl, Emre M Isin, Robert L Eoff, et al.
Biochemistry|December 24, 2019
Water Networks and Correlated Motions in Mutant Isocitrate Dehydrogenase 1 (IDH1) Are Critical for Allosteric Inhibitor Binding and ActivityJennifer M Chambers, Wade Miller, Giovanni Quichocho, et al.
Molecular Pharmacology|April 20, 2012
Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptaseChristal D Sohl, Rajesh Kasiviswanathan, Jiae Kim, et al.
CBE Life Sciences Education|August 22, 2024
The Making of Future Scientists: Faculty Mentor Cultural Awareness and Inclusive Science LabsIvan A Hernandez, Oliva Mota Segura, Rosalva Romero Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γChristal D Sohl, Michal R Szymanski, Andrea C Mislak, et al.
Biochemistry|February 28, 2023
Capturing the Dynamic Conformational Changes of Human Isocitrate Dehydrogenase 1 (IDH1) upon Ligand and Metal Binding Using Hydrogen-Deuterium Exchange Mass SpectrometryKaitlyn A Sabo, Elene Albekioni, Danielle Caliger, et al.
The Journal of Biological Chemistry|March 24, 2017
Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiencyDiego Avellaneda Matteo, Adam J Grunseth, Eric R Gonzalez, et al.
Biochemistry|April 3, 2023
Insights into Nitrosoalkane Binding to Myoglobin Provided by Crystallography of Wild-Type and Distal Pocket Mutant DerivativesViridiana E Herrera, Tatyana P Charles, Tiala G Scott, et al.
The Biochemical Journal|September 26, 2018
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutantsDiego Avellaneda Matteo, Grace A Wells, Lucas A Luna, et al.
Pageof 4